251 related articles for article (PubMed ID: 28241245)
1. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Lakdawala NK; Thune JJ; Maron BJ; Cirino AL; Havndrup O; Bundgaard H; Christiansen M; Carlsen CM; Dorval JF; Kwong RY; Colan SD; Køber LV; Ho CY
Am J Cardiol; 2011 Dec; 108(11):1606-13. PubMed ID: 21943931
[TBL] [Abstract][Full Text] [Related]
3. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
Ho CY; Lakdawala NK; Cirino AL; Lipshultz SE; Sparks E; Abbasi SA; Kwong RY; Antman EM; Semsarian C; González A; López B; Diez J; Orav EJ; Colan SD; Seidman CE
JACC Heart Fail; 2015 Feb; 3(2):180-8. PubMed ID: 25543971
[TBL] [Abstract][Full Text] [Related]
4. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
7. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Vissing CR; Axelsson Raja A; Day SM; Russell MW; Zahka K; Lever HM; Pereira AC; Colan SD; Margossian R; Murphy AM; Canter C; Bach RG; Wheeler MT; Rossano JW; Owens AT; Benson L; Mestroni L; Taylor MRG; Patel AR; Wilmot I; Thrush P; Soslow JH; Becker JR; Seidman CE; Lakdawala NK; Cirino AL; McMurray JJV; MacRae CA; Solomon SD; Bundgaard H; Orav EJ; Ho CY;
JAMA Cardiol; 2023 Nov; 8(11):1083-1088. PubMed ID: 37672268
[TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
[TBL] [Abstract][Full Text] [Related]
10. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
[TBL] [Abstract][Full Text] [Related]
11. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
[TBL] [Abstract][Full Text] [Related]
12. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.
Captur G; Lopes LR; Patel V; Li C; Bassett P; Syrris P; Sado DM; Maestrini V; Mohun TJ; McKenna WJ; Muthurangu V; Elliott PM; Moon JC
Circ Cardiovasc Genet; 2014 Jun; 7(3):241-8. PubMed ID: 24704860
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
14. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
[TBL] [Abstract][Full Text] [Related]
15. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.
Captur G; Lopes LR; Mohun TJ; Patel V; Li C; Bassett P; Finocchiaro G; Ferreira VM; Esteban MT; Muthurangu V; Sherrid MV; Day SM; Canter CE; McKenna WJ; Seidman CE; Bluemke DA; Elliott PM; Ho CY; Moon JC
Circ Cardiovasc Imaging; 2014 Nov; 7(6):863-71. PubMed ID: 25228707
[TBL] [Abstract][Full Text] [Related]
16. Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic
Parbhudayal RY; Harms HJ; Michels M; van Rossum AC; Germans T; van der Velden J
J Am Heart Assoc; 2020 Apr; 9(8):e015316. PubMed ID: 32290750
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
[TBL] [Abstract][Full Text] [Related]
18. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.
Grover S; Lloyd R; Perry R; Lou PW; Haan E; Yeates L; Woodman R; Atherton JJ; Semsarian C; Selvanayagam JB
Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):932-938. PubMed ID: 30668650
[TBL] [Abstract][Full Text] [Related]
19. Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy.
Finocchiaro G; Dhutia H; D'Silva A; Malhotra A; Sheikh N; Narain R; Ensam B; Papatheodorou S; Tome M; Sharma R; Papadakis M; Sharma S
J Am Soc Echocardiogr; 2018 May; 31(5):606-613.e1. PubMed ID: 29482976
[TBL] [Abstract][Full Text] [Related]
20. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
Ho CY
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
